QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 0.0001
-- x --
-- x --
-- - --
$ 0.00 - $ 0.00
2,500
na
na
$ 0.77
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

 why-fangdd-network-group-shares-are-trading-higher-by-around-78-here-are-20-stocks-moving-premarket

Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2...

 gds-holdings-coinbase-and-other-big-stocks-moving-higher-in-mondays-pre-market-session

U.S. stock futures were lower this morning, with the Dow futures falling by around 100 points on Monday. Shares of GDS Holdin...

 lenz-therapeutics-graphite-bio-enter-definitive-merger-agreement-to-combine-companies-in-an-all-stock-transaction

The combined company is expected to trade on Nasdaq under the ticker symbol "LENZ." With the cash expected from both co...

 graphite-bio-reports-departure-of-cfo-alethia-young

Young, who will step down from her position to pursue other opportunities, will remain with the Company through June 30, 2023, ...

 rbc-capital-maintains-sector-perform-on-graphite-bio-lowers-price-target-to-3

RBC Capital analyst Luca Issi maintains Graphite Bio (NASDAQ:GRPH) with a Sector Perform and lowers the price target from $4...

 graphite-bio-q4-eps-044-beats-049-estimate

Graphite Bio (NASDAQ:GRPH) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.49) ...

 b-of-a-securities-downgrades-graphite-bio-to-underperform-lowers-price-target-to-2

B of A Securities analyst Geoff Meacham downgrades Graphite Bio (NASDAQ:GRPH) from Neutral to Underperform and lowers the pr...

 cantor-fitzgerald-downgrades-graphite-bio-to-neutral-lowers-price-target-to-3

Cantor Fitzgerald analyst Olivia Brayer downgrades Graphite Bio (NASDAQ:GRPH) from Overweight to Neutral and lowers the pric...